Found: 32
Select item for more details and to access through your institution.
Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 681, doi. 10.1093/jac/dkr534
- By:
- Publication type:
- Article
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2705, doi. 10.3390/pharmaceutics15122705
- By:
- Publication type:
- Article
Darunavir/cobicistat showing similar effectiveness as darunavir/ ritonavir monotherapy despite lower trough concentrations.
- Published in:
- Journal of the International AIDS Society, 2018, v. 21, n. 2, p. 1, doi. 10.1002/jia2.25072
- By:
- Publication type:
- Article
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 432, doi. 10.3390/antibiotics12030432
- By:
- Publication type:
- Article
Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 1, p. 45, doi. 10.3390/antibiotics11010045
- By:
- Publication type:
- Article
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 10, p. 657, doi. 10.3390/antibiotics9100657
- By:
- Publication type:
- Article
Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial.
- Published in:
- Stem Cells Translational Medicine, 2021, v. 10, n. 4, p. 534, doi. 10.1002/sctm.20-0213
- By:
- Publication type:
- Article
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.912579
- By:
- Publication type:
- Article
Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048959
- By:
- Publication type:
- Article
Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1551, doi. 10.3390/jcm11061551
- By:
- Publication type:
- Article
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 7, doi. 10.3390/jcm11010007
- By:
- Publication type:
- Article
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19.
- Published in:
- Microorganisms, 2021, v. 9, n. 11, p. 2259, doi. 10.3390/microorganisms9112259
- By:
- Publication type:
- Article
Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.802
- By:
- Publication type:
- Article
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 1, p. 1, doi. 10.1002/ctm2.704
- By:
- Publication type:
- Article
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1257725
- By:
- Publication type:
- Article
SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
- Published in:
- 2021
- By:
- Publication type:
- Letter
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 4, p. 551, doi. 10.1093/cid/cix358
- By:
- Publication type:
- Article
Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 2, p. 268, doi. 10.1093/cid/cit693
- By:
- Publication type:
- Article
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0269875
- By:
- Publication type:
- Article
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1423734
- By:
- Publication type:
- Article
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events.
- Published in:
- Annals of Internal Medicine, 2009, v. 151, n. 3, p. 149
- By:
- Publication type:
- Article
Absolute CD4<sup>+</sup> T cell count overstate immune recovery assessed by CD4<sup>+</sup>/CD8<sup>+</sup> ratio in HIV-infected patients on treatment.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0205777
- By:
- Publication type:
- Article
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203452
- By:
- Publication type:
- Article
Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 10, p. 2451, doi. 10.1093/jac/dkad251
- By:
- Publication type:
- Article
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2354, doi. 10.1093/jac/dkad245
- By:
- Publication type:
- Article
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 8, p. e84, doi. 10.1086/605677
- By:
- Publication type:
- Article
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection.
- Published in:
- Clinical Infectious Diseases, 2007, v. 45, n. 8, p. 969, doi. 10.1086/521857
- By:
- Publication type:
- Article